Today
Mostly cloudy skies early then heavy thunderstorms developing this afternoon. Storms may contain strong gusty winds. High around 80F. Winds WSW at 5 to 10 mph. Chance of rain 90%..
Tonight
Mostly cloudy with scattered thunderstorms mainly during the evening. Storms may contain strong gusty winds. Low 64F. Winds light and variable. Chance of rain 60%. Updated: July 17, 2021 @ 10:17 am
Pfizer Agrees to Pay $345 Million Under Proposed Settlement Over EpiPen Price Hikes
By the Associated Press.
Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve litigation over EpiPen price hikes.
The New York-based Pfizer and its subsidiaries–Maryland-based Meridian Medical Technologies Inc. and Tennessee-based King Pharmaceuticals–asked a federal court in Kansas City, Kansas, on Thursday to grant preliminary approval to the settlement.
Numerous class action lawsuits were filed alleging the companies engaged in anticompetitive conduct. EpiPens are auto-injectable devices that deliver the drug epinephrine and are used to treat life-threatening allergic reactions.
Pfizer, Subsidiaries Agree to Pay $345M in EpiPen Settlement EpiPens, auto-injectable devices that deliver the drug epinephrine, are used for emergency treatment of a life-threatening allergic reaction
Published July 15, 2021
AP
Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve lawsuits over EpiPen price hikes.
In documents filed Thursday in federal court in Kansas City, Kansas, the New York-based Pfizer and its subsidiaries Maryland-based Meridian Medical Technologies Inc. and Tennessee-based King Pharmaceuticals asked the court to grant preliminary approval to the settlement, Kansas City s NPR station KCUR-FM reported. Don t miss local breaking news and weather. Download
Published July 16. 2021 12:44AM | Updated July 16. 2021 1:02AM Get the weekly rundown Email Submit
KANSAS CITY, Kan. (AP) Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve lawsuits over EpiPen price hikes.
In documents filed Thursday in federal court in Kansas City, Kan., the New York-based Pfizer and its subsidiaries Maryland-based Meridian Medical Technologies Inc. and Tennessee-based King Pharmaceuticals asked the court to grant preliminary approval to the settlement, Kansas City s NPR station KCUR-FM reported.
The litigation dates to 2016, when numerous class-action lawsuits were filed around the country alleging that the companies engaged in anticompetitive conduct related to EpiPen. The cases were transferred to the Kansas court because of its centralized location.
Pfizer, subsidiaries agree to pay $345M in EpiPen settlement startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.